Armistice Capital’s Evolus EOLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.97M Buy
1,436,000
+40,000
+3% +$236K 0.12% 110
2026
Q1
$5.74M Buy
1,396,000
+420,000
+43% +$2.04M 0.1% 118
2025
Q4
$6.49M Buy
+976,000
New +$6.61M 0.08% 118
2024
Q4
Sell
-360,000
Closed -$5.83M 260
2024
Q3
$5.83M Hold
360,000
0.09% 115
2024
Q2
$3.91M Buy
+360,000
New +$4.43M 0.05% 122

Other funds holding EOLS

Armistice Capital's EOLS Position: Q2 2026 in Review

Armistice Capital increased its Evolus (EOLS) stake by 2.9% in Q2 2026, buying an estimated $236K and bringing the position to 1,436,000 shares worth $9.97M. The position accounts for 0.12% of the portfolio, ranked #110.

Armistice Capital first reported a position in EOLS in Q2 2024 and has held it in 5 quarters since. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Armistice Capital held 1,436,000 shares of Evolus worth $9.97M as of Q2 2026.
  • Armistice Capital bought 40,000 Evolus shares in Q2 2026, an estimated $236K.
  • Evolus made up 0.12% of Armistice Capital's portfolio in Q2 2026, its #110 holding.
  • Armistice Capital first reported a position in Evolus in Q2 2024 and has held it in 5 quarters since.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.